Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

08/05/2020 07:00

May 8 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2020        Mar 31, 2019     Dec 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            70 mln              48 mln                     
                 (+45.2 pct)         (+42.8 pct)                  
  Operating     loss 287 mln        loss 364 mln                  
  Recurring     loss 285 mln        loss 359 mln                  
  Net           loss 286 mln        loss 360 mln                  
  EPS          loss 19.96 yen      loss 26.91 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T